ELEVECTA
Live / Registered — Registered (as of 28 Jul 2020)
What this means for you
Registered since 28 Jul 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79272524
- Registration number
- 6110170
- Mark type
- Stylized text
- Filed
- 12 Aug 2019
- Published for opposition
- 12 May 2020
- Registered
- 28 Jul 2020
- Attorney of record
- Dyan M. House
Goods and services
- Class 001 — Chemicals: Chemical, biological and biochemical reagents for scientific, research, laboratory, industrial and commercial purposes; Chemical, biological and biochemical substances and preparations for scientific, research and laboratory use; chemical, biological and biochemical substances, preparations and reagents for research use in characterizing diseases; chemical, biological and biochemical substances, preparations and reagents for scientific and medical research and drug development; chemical, biological and biochemical substances, preparations and reagents for manufacturing drugs and pharmaceuticals; cultures of microorganisms and viruses, other than for medical or veterinary purposes, in particular adeno-associated viruses; proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells, other than for medical or veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing stable or transient transfected eukaryotic cell lines and eukaryotic cells, other than for medical or veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells for scientific, research, laboratory, industrial and commercial purposes, namely, for manufacturing viral vectors, in particular vectors of adeno-associated viruses
- Class 005 — Pharmaceuticals: Medicines for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; pharmaceutical and veterinary products, preparations and reagents for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; chemical, biological and biochemical substances, preparations and reagents for medical and veterinary purposes, namely, for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; diagnostic and analytical preparations for medical and veterinary purposes; cultures of microorganisms and viruses for medical or veterinary purposes, in particular adeno-associated viruses; proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells for medical or veterinary purposes, namely, for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing stable or transient transfected eukaryotic cell lines and eukaryotic cells, for medical and veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing viral vectors, in particular vectors of adeno-associated viruses, for medical, veterinary and medical diagnostic purposes
- Class 042 — Scientific and technological services: Scientific and industrial research, in particular in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures, and expression systems in the nature of microorganisms, insect cells, and mammalian cells; scientific, technical and industrial research consultancy, in particular in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific laboratory services, namely, cultivation, extraction, optimization, synthesizing and modifying of eukaryotic cell lines, eukaryotic cells, in particular transfecting and selecting of eukaryotic cells and eukaryotic cell lines with a nucleic acid, in particular a plasmid, viruses, in particular adeno-associated viruses, viral vectors, in particular vectors of adeno-associated viruses, polypeptides, proteins, nucleotides, nucleic acids, for third parties for scientific, research, laboratory, development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific analysis, research and development in the nature of analysis and selection of transfected eukaryotic cells and eukaryotic cell lines and viral vectors, in particular vectors of adeno-associated viruses, for third parties for scientific, research, laboratory, development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics
Owner
Prosecution history
- 29 Jan 2026 — TEAS SECTION 71 & 15 RECEIVED
- 28 Jul 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 18 Oct 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 09 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Aug 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 09 Aug 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Aug 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Aug 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Aug 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Nov 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 21 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Aug 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 21 Aug 2023 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 21 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED